| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +200K | 18.6% | $18.39 | +$3.68M |
| Sells | 6 | -874K | 81.4% | $29.09 | -$25.4M |
| Net | -5 | -674K | -62.8% | -$21.8M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Andrew Cheng | President and CEO, Director | $19.7M | -$9.64M | -32.9% | Nov 1, 2024 |
| Jonathan Young | Chief Operating Officer | $15.7M | -$4.02M | -20.4% | Nov 1, 2024 |
| Timothy Rolph | Chief Scientific Officer | $4.73M | -$96.2K | -1.99% | Sep 10, 2024 |
| Catriona Yale | Chief Development Officer | $2.14M | -$3.53M | -62.3% | Nov 15, 2024 |
| Skorpios Trust | Former 10% owner | $2.01M | Dec 1, 2022 | ||
| William Richard White | Chief Financial Officer | $1.08M | -$8.13M | -88.3% | Sep 10, 2024 |
| G. Walmsley Graham | Director | $493K | +$3.68M | Jun 8, 2024 | |
| Patrick Lamy | Senior VP, Commercial Strategy | $375K | -$12.9K | -3.33% | Jun 28, 2024 |
| Seth Loring Harrison | Director | Jun 8, 2024 | |||
| Chou Judy | Director | Jun 8, 2024 | |||
| Mark T. Iwicki | Director | Jun 8, 2024 | |||
| Yuan Xu | Director | Jun 8, 2024 | |||
| Tomas J. Heyman | Director | Jun 8, 2024 | |||
| Kevin Bitterman | Director | Jun 1, 2021 | |||
| Scott A. Gangloff | Chief Technology Officer | Apr 29, 2024 | |||
| ATP Life Science Ventures, L.P. | 10%+ Owner | Jun 28, 2021 | |||
| Jane Henderson | Director | Jun 8, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|